<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-07T11:38:29+00:00">
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-BDI-Z-UNDP-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Programme to Accelerate the Reduction of Transmission of the HIV and Tuberculosis Epidemic and to Improve Malaria Management in Burundi (PACTEAPEC) - Burundi (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Burundi, Multicomponent, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Contribuer à mettre fin aux épidémies du VIH, des IST, des Hépatites virales comme ménace pour la santé publique d'ici 2030 au Burundi, en Réduisant les nouvelles infections , les décès et la discrimination/stigmatisation // Contribute to ending the epidemics of HIV, STIs and viral hepatitis as a public health threat by 2030 in Burundi, by reducing new infections, deaths and discrimination/stigmatization; Mettre fin à la tendance épidémique de la tuberculose au Burundi afin de libérer la population du fardeau lié à la TB et ses comorbidité pour sa participation au dévelopment du pays // Put an end to the epidemic trend of tuberculosis in Burundi in order to free the population from the burden of TB and its co-morbidities and allow them to participate in the country's development; Doter à la population vivant sur le territoire burundais des outils et services les plus efficaces de lutte contre le Paludisme (mission) // Provide the population living in Burundi with the most effective tools and services to fight malaria (mission); Contribuer à la réduction de la mortalité, des handicaps et invalidités évitables par l’offre et l’utilisation des services de santé de qualité à toute la population qui en a besoin // Contribute to the reduction of avoidable mortality and disabilities through the provision and use of quality health services to the entire population in need. Objectives: Résultat d’Impact 1 : D’ici 2027, les nouvelles infections à VIH/IST/HV sont réduites d’au moins 70 %, en particulier pour les populations les plus exposées // Impact Outcome 1: By 2027, new HIV/STI/Hep infections are reduced by at least 70%, particularly for most-at-risk populations; Résultat d’Impact 2 : D’ici 2027, la morbi-mortalité liée au VIH /IST est réduite d’au moins 70% et d’au moins 65% des décès liés aux hépatites virales // Impact Outcome 2: By 2027, HIV/STI-related morbidity and mortality is reduced by at least 70% and viral hepatitis-related deaths by at least 65%; Résultat d’impact 3 : D’ici 2027, l’environnement lié aux droits humains et au genre est amélioré pour lever les barrières de l’accès aux services de prévention de prise e charge du VIH, des IST et des HV y compris la suppression des coûts catastrophiques // Impact outcome 3: By 2027, the human rights and gender environment is improved to remove barriers to accessing HIV, STI and Hepatitis prevention and care services, including the elimination of catastrophic costs; Résultat d’impact 4 : D’ici 2027, la gouvernance est renforcée pour maintenir les performances, l’efficience, la redevabilité et la durabilité de la réponse nationale au VIH/IST/HV sous le leadership du CNLS // Impact outcome 4: By 2027, governance is strengthened to maintain the performance, efficiency, accountability and sustainability of the national response to HIV/STI/Hep under the leadership of the CNLS; D'ici 2027, contribuer à la réduction de la morbidité et de la mortalité due à la tuberculose ainsi que les coûts catastrophique ainsi que la réduction de 75% des décès (par rapport  à 2015) et 50% de l'incidence ( par rapport à 2015) // By 2027, contribute to the reduction of morbidity and mortality due to tuberculosis as well as catastrophic costs, with a 75% reduction in deaths (compared to 2015) and a 50% reduction in incidence (compared to 2015); Réduire de 60% la morbidité et à 0% la mortalité liée au Paludisme au Burundi // Reduce malaria-related morbidity by 60% and mortality to 0% in Burundi; D'ici 2026, le score global de complétude et promptitude de la qualité des données du système d'information sanitaire de routine passe respectivement de 81% à 92% et de 56% à 75% // By 2026, the overall score for completeness and timeliness of routine health information system data quality will rise from 81% to 92% and from 56% to 75% respectively.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="BDI-Z-UNDPP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="BI" percentage="100">
      <narrative>Burundi</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12262" percentage="56.15">
      <narrative>Malaria</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="20.99">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="18.71">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="4.15">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="d0aef99a-6d26-4e24-9937-7363cf44e158" percentage="0">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e41c9e1f-dfcd-4d62-9a3d-2c6d760bb3af" percentage="0">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="26ab57aa-470b-4e99-bff9-92e1452cf6cd" percentage="0.38">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="48867067-7709-4cef-94a9-7dcc66211686" percentage="0.1">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="fa74be82-0e67-471f-99cd-c36d38ba6843" percentage="0.32">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Early infant diagnosis and follow-up HIV testing for exposed infants</narrative>
        </description>
      </budget-item>
      <budget-item code="54f285ef-8db0-40b2-8052-f00a00522b8d" percentage="1.43">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
        </description>
      </budget-item>
      <budget-item code="3eb32c17-6380-4aa6-8a3b-73b4cb922dee" percentage="0.14">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Post-natal infant prophylaxis</narrative>
        </description>
      </budget-item>
      <budget-item code="698ea3f4-346f-4df8-ab2e-c01a47bbccd9" percentage="0.09">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Prevention of incident HIV among pregnant and breastfeeding women</narrative>
        </description>
      </budget-item>
      <budget-item code="1ef60004-7321-4f53-93cf-6bdfa56924ef" percentage="0.11">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Retention support for pregnant and breastfeeding women (facility and community)</narrative>
        </description>
      </budget-item>
      <budget-item code="e71b58f8-6d5d-4f73-93c5-cea93aefb0c3" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for AGYW and male sexual partners in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="92423e34-c66c-47f4-9cac-58b9e0ea01fc" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Community empowerment for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="0.08">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="86dc2898-1dfb-4559-a4cb-72cd5a2cd403" percentage="0.15">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="e14e7a7d-49ce-4bb6-8454-ae4224e7a32e" percentage="0.04">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="52020c8d-d3b6-42f6-9137-038784523b8a" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Condom and lubricant programming for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="d01264fd-1485-4b1a-b85c-fbaa2fa20933" percentage="0.14">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="8de4adae-a667-40e7-aadf-a32b8a82065a" percentage="0.1">
        <description>
          <narrative>HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; Condom and lubricant programming for prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="09268318-342f-41af-84e1-0aab4e2fd8f3" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Community empowerment for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="1d7ecc3b-d5b9-48ca-a9e7-d8fa38cf3455" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Condom and lubricant programming for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="d4788f0c-523b-415c-b8ec-03eaa8789e31" percentage="0.04">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; HIV prevention communication, information and demand creation for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="49ef45b6-ef30-48b1-b393-f34c25d513c4" percentage="0.42">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Opioid substitution therapy and other medically assisted drug dependence treatment for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="e2889950-b814-4736-95c3-6957c4461ebe" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="d016d725-1006-44b1-8b50-da67f4621072" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="12d964e1-5c4b-4caa-9b00-225bb89861dd" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Community empowerment for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="94dbd87e-0cec-46fb-83f5-7c805de185cb" percentage="0.83">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="394d6538-8808-4811-b96b-d6bf71843cb6" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; HIV prevention communication, information and demand creation for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="4ad468bf-4376-466e-944a-b25f3e1b00ee" percentage="0.08">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="3f39233d-f679-42ce-8532-a7949f0d93ef" percentage="0.13">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="e6662a80-0f0d-4611-990c-6044696834dc" percentage="0">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy for human rights</narrative>
        </description>
      </budget-item>
      <budget-item code="28c1900d-472f-4af5-94d7-2b92f93ab743" percentage="0.06">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Increasing access to justice (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="ecc245de-32bf-41ff-8eb1-f5fae2eb1557" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights") (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="530c3ad4-ec67-412e-9dc9-b83b6de6bf61" percentage="0.08">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Diagnosis and management of advanced HIV disease (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="8.3">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="6bb2376e-8c74-4cf1-98f0-f72ea58797fa" percentage="0.14">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
        </description>
      </budget-item>
      <budget-item code="423a40f4-4716-48a1-9c6c-7b78ede223af" percentage="1.3">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Integrated management of common co-infections and co-morbidities (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="f4ee9261-d065-449a-8c27-d7a734d6ccae" percentage="0.54">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Drug resistance</narrative>
        </description>
      </budget-item>
      <budget-item code="75665eb3-7cb7-4083-b197-c97fcbe30044" percentage="3.52">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
        </description>
      </budget-item>
      <budget-item code="be1b5900-2300-4fc2-b142-10ef3d0c2a60" percentage="0.02">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Epidemic preparedness</narrative>
        </description>
      </budget-item>
      <budget-item code="738953d0-45d2-486f-957e-e3fee8de75cd" percentage="12.44">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Facility-based treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="c0797acd-77a1-43ee-9c39-6bf17fd6f4ed" percentage="3.27">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Integrated community case management (iCCM)</narrative>
        </description>
      </budget-item>
      <budget-item code="b0e40e02-4bcd-40a8-840c-b8260e492c4c" percentage="0.86">
        <description>
          <narrative>Malaria -&gt; Specific prevention interventions (SPI) -&gt; Intermittent preventive treatment (IPT) - In pregnancy</narrative>
        </description>
      </budget-item>
      <budget-item code="4a9e4a3b-ef67-433f-a29c-62adac95c673" percentage="0.32">
        <description>
          <narrative>Malaria -&gt; Specific prevention interventions (SPI) -&gt; Perennial malaria chemoprevention (PMC)</narrative>
        </description>
      </budget-item>
      <budget-item code="58ca89db-1015-4f6f-a881-b8a766ce0ea5" percentage="0.03">
        <description>
          <narrative>Malaria -&gt; Specific prevention interventions (SPI) -&gt; Removing human rights and gender-related barriers to specific prevention interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="f4134963-9477-4972-86b5-4a0048ce0063" percentage="0.1">
        <description>
          <narrative>Malaria -&gt; Specific prevention interventions (SPI) -&gt; Social and behavior change (SBC) (Specific prevention interventions)</narrative>
        </description>
      </budget-item>
      <budget-item code="8a9aef0d-fc01-47c9-bc48-61216a92e266" percentage="5.06">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Indoor residual spraying (IRS)</narrative>
        </description>
      </budget-item>
      <budget-item code="479fb4f4-6792-4b4c-92a8-c428d9c4dddb" percentage="0.17">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Insecticide treated nets (ITNs) - Continuous distribution: ANC</narrative>
        </description>
      </budget-item>
      <budget-item code="ec73574f-f014-44eb-a8c7-9791b58bc103" percentage="0.04">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Insecticide treated nets (ITNs) - Continuous distribution: EPI</narrative>
        </description>
      </budget-item>
      <budget-item code="cc538db4-0648-45de-a10f-3cb58de9a270" percentage="0.41">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Insecticide treated nets (ITNs) - Continuous distribution: community-based</narrative>
        </description>
      </budget-item>
      <budget-item code="0904e74b-3fd7-4544-bb4e-8343228bdbe5" percentage="33.4">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Insecticide treated nets (ITNs) - Mass campaign: universal</narrative>
        </description>
      </budget-item>
      <budget-item code="a58d3044-b095-4df4-b7b7-c7df42d56d3d" percentage="0.03">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Social and behavior change (SBC) (Vector control)</narrative>
        </description>
      </budget-item>
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="0.23">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="17.51">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="0.64">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="1.96">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="178ad552-8e84-49d7-8952-4e30d00c6364" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; RSSH/PP: Surveillance for priority epidemic-prone diseases and events</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="0.39">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="1a5ab4c7-9695-4567-adb4-0a3768fa01ee" percentage="0.24">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="fd4720c3-77e8-4b8a-8c90-69c1ae68c5e7" percentage="0.1">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Collaboration with other programs/sectors</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="0.84">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="0.35">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="0.14">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcbb01c-6f63-414e-a67b-9a54f6bd04c0" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Miners and mining communities</narrative>
        </description>
      </budget-item>
      <budget-item code="1ed5e501-534e-43ae-bb9f-9552bd6bf461" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Mobile population (migrants/refugees/IDPs)</narrative>
        </description>
      </budget-item>
      <budget-item code="03989069-d574-46fc-9fad-200e03cde744" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="99e62de4-459a-4fc3-a5da-f5297d23736d" percentage="0.06">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
        </description>
      </budget-item>
      <budget-item code="8d2f8312-6339-4e40-9c64-84e09bb628b3" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Urban poor/slum dwellers</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="0.99">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="1.02">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="7332ed72-b538-4ab5-b90e-f820e56c0c5b" percentage="0.26">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
        </description>
      </budget-item>
      <budget-item code="d98eb915-d64b-45bb-8bae-93a530d37d6e" percentage="0.03">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Community care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="602586f6-9a77-484c-bf39-acc8a3151170" percentage="0.12">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.07">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="c03db068-1593-4995-bf69-fe67549bd239" percentage="0.13">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Treatment and care</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">19294693.12</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">66960910.75</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">23093581.69</value>
    </budget>
    <capital-spend percentage="2.14" />
    <transaction ref="59ec0194-a8d8-413c-ba4e-1c5fc21ae22e">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-16" />
      <value currency="USD" value-date="2024-01-16">77587759.00</value>
      <description>
        <narrative>Global Fund commitment to BDI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3a530d66-6ee7-414c-ae42-3778a40ff9d8">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-18" />
      <value currency="USD" value-date="2024-01-18">9136513.00</value>
      <description>
        <narrative>Global Fund disbursement to BDI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="37d07687-8565-402d-8cbb-019275dc4e08">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-02-27" />
      <value currency="USD" value-date="2024-02-27">31955898.00</value>
      <description>
        <narrative>Global Fund disbursement to BDI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c8820f9e-1e46-483f-9b25-8a64945ed44a">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-10" />
      <value currency="USD" value-date="2024-12-10">36085969.00</value>
      <description>
        <narrative>Global Fund disbursement to BDI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c7a97744-a81e-4738-990b-43a20a9bede4">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">4487876.00</value>
      <description>
        <narrative>Global Fund commitment to BDI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e69e3ca8-3554-4b52-a35c-d514461c6641">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">4487876.00</value>
      <description>
        <narrative>Global Fund disbursement to BDI-Z-UNDPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="47a650a2-ab21-47a3-9de0-d00274423d57">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-11" />
      <value currency="USD" value-date="2025-08-11">-409379.00</value>
      <description>
        <narrative>Global Fund commitment to BDI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b007d664-64a9-445b-b7a4-70cec8c94225">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-11" />
      <value currency="USD" value-date="2025-08-11">14885730.00</value>
      <description>
        <narrative>Global Fund commitment to BDI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4d2c3096-f9e2-4ef1-904a-280dc01ff341">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-19" />
      <value currency="USD" value-date="2025-08-19">3199377.00</value>
      <description>
        <narrative>Global Fund disbursement to BDI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="99feaf83-dec0-459c-b927-0a4207da87ac">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-18" />
      <value currency="USD" value-date="2025-12-18">10629139.00</value>
      <description>
        <narrative>Global Fund disbursement to BDI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6c315d89-46fd-40dc-a201-1bf52f2b3c43">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-03" />
      <value currency="USD" value-date="2026-08-03">11521273.94</value>
      <description>
        <narrative>Global Fund commitment to BDI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="88bc9d9a-c343-4af4-9015-0b42f833c912">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-08-03" />
      <value currency="USD" value-date="2026-08-03">-1057214.00</value>
      <description>
        <narrative>Global Fund commitment to BDI-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="82712f80-5ac5-4116-a070-0662780e5300">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-11" />
      <value currency="USD" value-date="2026-08-11">9714199.85</value>
      <description>
        <narrative>Global Fund disbursement to BDI-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="BDI-Z-UNDPP01-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">19294693.13</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for BDI-Z-UNDPP01, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="BDI-Z-UNDPP01-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">53449213.34</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for BDI-Z-UNDPP01, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/BDI-Z-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-07" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="97.82">
          <comment>
            <narrative>Numerator: 5656533; Denominator: 5782482.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="97">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 3525654.15; Denominator: 3634695.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="97">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 3525654.15; Denominator: 3634695.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="97.92">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 2103215; Denominator: 2147787.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="97.92">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 2103215; Denominator: 2147787.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 4986542.8; Denominator: 5036912.</narrative>
            </comment>
          </target>
          <actual value="97.6">
            <comment>
              <narrative>Numerator: 4185594; Denominator: 4288476.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="99">
            <comment>
              <narrative>Numerator: 2493271.44; Denominator: 2518456.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 2493271.44; Denominator: 2518456.</narrative>
            </comment>
          </target>
          <actual value="98.04">
            <comment>
              <narrative>Numerator: 2275964; Denominator: 2321403.</narrative>
            </comment>
          </actual>
          <actual value="98.11">
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 1477139; Denominator: 1505540.</narrative>
            </comment>
          </actual>
          <actual value="97.92">
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 798825; Denominator: 815760.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="99">
            <comment>
              <narrative>Numerator: 2328292; Denominator: 2351810.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 4656584; Denominator: 4703620.</narrative>
            </comment>
          </target>
          <actual value="97.16">
            <comment>
              <narrative>Numerator: 3389239; Denominator: 3488440.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="99">
            <comment>
              <narrative>Numerator: 2328292; Denominator: 2351810.</narrative>
            </comment>
          </target>
          <actual value="95.47">
            <comment>
              <narrative>Numerator: 1354064; Denominator: 1418301.</narrative>
            </comment>
          </actual>
          <actual value="97.18">
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 2341388; Denominator: 2409249.</narrative>
            </comment>
          </actual>
          <actual value="97.1">
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 1047847; Denominator: 1079169.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 2029433; Denominator: 2029433.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 2029433; Denominator: 2029433.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="98.32">
          <comment>
            <narrative>Numerator: 1317646; Denominator: 1340208.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="98.32">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 225317; Denominator: 229176.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="98.32">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 225317; Denominator: 229176.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="98.32">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 1092328.53; Denominator: 1111032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="98.32">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 1092328.53; Denominator: 1111032.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1658362; Denominator: 1658362.</narrative>
            </comment>
          </target>
          <actual value="101.6">
            <comment>
              <narrative>Numerator: 1221428; Denominator: 1202182.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 829181; Denominator: 829181.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 829181; Denominator: 829181.</narrative>
            </comment>
          </target>
          <actual value="101.46">
            <comment>
              <narrative>Numerator: 587641; Denominator: 579192.</narrative>
            </comment>
          </actual>
          <actual value="93.09">
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 153310; Denominator: 164684.</narrative>
            </comment>
          </actual>
          <actual value="104.78">
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 434331; Denominator: 414508.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 903096; Denominator: 903096.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1806192; Denominator: 1806192.</narrative>
            </comment>
          </target>
          <actual value="101.11">
            <comment>
              <narrative>Numerator: 925083; Denominator: 914935.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 903096; Denominator: 903096.</narrative>
            </comment>
          </target>
          <actual value="100.19">
            <comment>
              <narrative>Numerator: 332284; Denominator: 331648.</narrative>
            </comment>
          </actual>
          <actual value="95.15">
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 226852; Denominator: 238422.</narrative>
            </comment>
          </actual>
          <actual value="103.21">
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 698231; Denominator: 676513.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 899982; Denominator: 899982.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 899982; Denominator: 899982.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 11099430; Denominator: 11117138; Percentage: 99.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 290409; Denominator: 291770; Percentage: 99.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 290409; Denominator: 291770; Percentage: 99.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 362982; Denominator: 364284; Percentage: 99.64%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 362982; Denominator: 364284; Percentage: 99.64%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Testing type" value="Microscopy" />
          <comment>
            <narrative>Numerator: 1654109; Denominator: 11099430; Percentage: 14.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 9445321; Denominator: 11099430; Percentage: 85.1%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 9658647.6; Denominator: 9668316; Percentage: 99.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8757331; Denominator: 8774091; Percentage: 99.81%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4829323.84; Denominator: 4834158; Percentage: 99.9%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4829323.84; Denominator: 4834158; Percentage: 99.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4470342; Denominator: 4477350; Percentage: 99.84%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 2865256; Denominator: 2869094; Percentage: 99.87%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 1605086; Denominator: 1608251; Percentage: 99.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4509767; Denominator: 4514281; Percentage: 99.9%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 9019534; Denominator: 9028562; Percentage: 99.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7289923; Denominator: 7295063; Percentage: 99.93%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4509767; Denominator: 4514281; Percentage: 99.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3194047; Denominator: 3196582; Percentage: 99.92%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 4861896; Denominator: 4864601; Percentage: 99.94%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 2429843; Denominator: 2432278; Percentage: 99.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Microscopy" />
            <comment>
              <narrative>Numerator: 1284425.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 6005498.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3891586; Denominator: 3895481; Percentage: 99.9%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3891586; Denominator: 3895481; Percentage: 99.9%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of suspected malaria cases that receive a parasitological test in the community</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Proportion of suspected malaria cases that receive a parasitological test in the community</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 1721513; Denominator: 1721513; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 368346; Denominator: 368346; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 368346; Denominator: 368346; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 1353167; Denominator: 1353167; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 1353167; Denominator: 1353167; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 1721513; Denominator: 1721513; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1065093; Denominator: 1065093; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2130186; Denominator: 2130186; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1632183; Denominator: 2175975; Percentage: 75.01%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1065093; Denominator: 1065093; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 758202; Denominator: 1110383; Percentage: 68.28%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 215727; Denominator: 711535; Percentage: 30.32%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 542475; Denominator: 398846; Percentage: 136.01%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2320076; Denominator: 2320076; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1207141; Denominator: 2024381; Percentage: 59.63%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1160038; Denominator: 1160038; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1160038; Denominator: 1160038; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 438027; Denominator: 887052; Percentage: 49.38%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 334520; Denominator: 1349927; Percentage: 24.78%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 872621; Denominator: 674957; Percentage: 129.29%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 1207141.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1156038; Denominator: 1156038; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1156038; Denominator: 1156038; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HTS-3a-Other 1 Percentage of men most exposed to HIV who were tested for HIV during the reporting period in programs specifically targeting at-risk populations and who know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>HTS-3a-Other 1 Percentage of men most exposed to HIV who were tested for HIV during the reporting period in programs specifically targeting at-risk populations and who know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="68.1">
          <comment>
            <narrative>Numerator: 7879; Denominator: 11570.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="29.6">
            <comment>
              <narrative>Numerator: 5805.2; Denominator: 19612.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="74">
            <comment>
              <narrative>Numerator: 14513; Denominator: 19612.</narrative>
            </comment>
          </target>
          <actual value="74.79">
            <comment>
              <narrative>Numerator: 14668; Denominator: 19612.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="74">
            <comment>
              <narrative>Numerator: 14513; Denominator: 19612.</narrative>
            </comment>
          </target>
          <actual value="74.79">
            <comment>
              <narrative>Numerator: 14668; Denominator: 19612.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="38.5">
            <comment>
              <narrative>Numerator: 7731.5; Denominator: 20082.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="77">
            <comment>
              <narrative>Numerator: 15463; Denominator: 20082.</narrative>
            </comment>
          </target>
          <actual value="76.51">
            <comment>
              <narrative>Numerator: 15364; Denominator: 20082.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="77">
            <comment>
              <narrative>Numerator: 15463; Denominator: 20082.</narrative>
            </comment>
          </target>
          <actual value="76.51">
            <comment>
              <narrative>Numerator: 15364; Denominator: 20082.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="36.45">
            <comment>
              <narrative>Numerator: 3421; Denominator: 9385.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="49.95">
            <comment>
              <narrative>Numerator: 4688; Denominator: 9385.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HTS-3c-Other 1. Percentage of women most exposed to HIV who were tested for HIV during the reporting period in programs specifically targeting at-risk populations and who know their status</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>HTS-3c-Other 1. Percentage of women most exposed to HIV who were tested for HIV during the reporting period in programs specifically targeting at-risk populations and who know their status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="59.64">
          <comment>
            <narrative>Numerator: 38010; Denominator: 63732.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 42867; Denominator: 61239.</narrative>
            </comment>
          </target>
          <actual value="93.39">
            <comment>
              <narrative>Numerator: 57189; Denominator: 61239.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="28">
            <comment>
              <narrative>Numerator: 17146.8; Denominator: 61239.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 42867; Denominator: 61239.</narrative>
            </comment>
          </target>
          <actual value="93.39">
            <comment>
              <narrative>Numerator: 57189; Denominator: 61239.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="37.5">
            <comment>
              <narrative>Numerator: 23516; Denominator: 62709.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 47032; Denominator: 62709.</narrative>
            </comment>
          </target>
          <actual value="67.62">
            <comment>
              <narrative>Numerator: 42405; Denominator: 62709.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 47032; Denominator: 62709.</narrative>
            </comment>
          </target>
          <actual value="67.62">
            <comment>
              <narrative>Numerator: 42405; Denominator: 62709.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="39.84">
            <comment>
              <narrative>Numerator: 26257; Denominator: 65906.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="52.29">
            <comment>
              <narrative>Numerator: 34462; Denominator: 65906.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2648; Denominator: 928; Percentage: 285.34%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 482; Denominator: 928; Percentage: 51.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2166; Denominator: 928; Percentage: 233.41%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1493.2; Denominator: 9824; Percentage: 15.2%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3733; Denominator: 9824; Percentage: 38%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4405; Denominator: 9824; Percentage: 44.84%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3733; Denominator: 9824; Percentage: 38%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4405; Denominator: 9824; Percentage: 44.84%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 4405.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2414.5; Denominator: 10060; Percentage: 24%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4829; Denominator: 10060; Percentage: 48%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4022; Denominator: 10060; Percentage: 39.98%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4829; Denominator: 10060; Percentage: 48%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4022; Denominator: 10060; Percentage: 39.98%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1811; Denominator: 6280; Percentage: 28.84%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2423; Denominator: 6280; Percentage: 38.58%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="46">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="46">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="0">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="0">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="21">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="25">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="39">
          <dimension name="HIV status" value="Negative" />
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="7">
          <dimension name="HIV status" value="Positive" />
        </baseline>
        <baseline year="2021" iso-date="2021-12-31" value="0">
          <dimension name="HIV status" value="Unknown" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="46" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="48" />
          <actual value="47" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="24" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="24" />
          <actual value="24" />
          <actual value="24">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="0">
            <dimension name="Age" value="&lt;15" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="54" />
          <actual value="44" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="27" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="27" />
          <actual value="23" />
          <actual value="43">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="1">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="9">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="35">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="41">
            <dimension name="HIV status" value="Negative" />
          </actual>
          <actual value="3">
            <dimension name="HIV status" value="Positive" />
          </actual>
          <actual value="0">
            <dimension name="HIV status" value="Unknown" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="32" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="32" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 46; Denominator: 46; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 46; Denominator: 46; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 46; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 46; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 21; Denominator: 21; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 21; Denominator: 21; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 0; Denominator: 46; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 0; Denominator: 46; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 25; Denominator: 25; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 25; Denominator: 25; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 46; Denominator: 46; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 46; Denominator: 46; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 46; Denominator: 46; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 48; Denominator: 48; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 47; Denominator: 47; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 24; Denominator: 24; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 24; Denominator: 24; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 24; Denominator: 24; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 24; Denominator: 24; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3; Denominator: 21; Percentage: 14.29%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 21; Denominator: 25; Percentage: 84%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 24.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 27; Denominator: 27; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 54; Denominator: 54; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 44; Denominator: 44; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 27; Denominator: 27; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 23; Denominator: 23; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 22; Denominator: 2.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 1; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2; Denominator: 2; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 42; Denominator: 42; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 23.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 32; Denominator: 32; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 32; Denominator: 32; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TBDT-1 other Number of patients under 15 with all forms of tuberculosis (i.e. bacteriologically confirmed and clinically diagnosed); *includes only new patients and relapses.</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>TBDT-1 other Number of patients under 15 with all forms of tuberculosis (i.e. bacteriologically confirmed and clinically diagnosed); *includes only new patients and relapses.</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 290.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 201.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 402.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 307.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 201.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 147.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 450.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 305; Denominator: 450; Percentage: 67.78%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 225.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 225.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 159; Denominator: 450; Percentage: 35.33%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 269.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 269.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TBDT-1 other Number of women reported with all forms of tuberculosis (i.e. bacteriologically confirmed and clinically diagnosed); *includes only new patients and relapses</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>TBDT-1 other Number of women reported with all forms of tuberculosis (i.e. bacteriologically confirmed and clinically diagnosed); *includes only new patients and relapses</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2195.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2558.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2460.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1279.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1279.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1249.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2697.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2563; Denominator: 2697; Percentage: 95.03%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1348.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1349.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1252; Denominator: 2697; Percentage: 46.42%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1421.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1421.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 60; Denominator: 60; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 60; Denominator: 60; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 60; Denominator: 64; Percentage: 93.75%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 94%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 94%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 44; Denominator: 50; Percentage: 88%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 94%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 25; Denominator: 30; Percentage: 83.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 25.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 94%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 40; Denominator: 47; Percentage: 85.11%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 94%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 94%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 20; Denominator: 24; Percentage: 83.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 94%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 94%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2859; Denominator: 5153; Percentage: 55.48%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 2656; Denominator: 5153; Percentage: 51.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 2656; Denominator: 5153; Percentage: 51.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 203; Denominator: 5153; Percentage: 3.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 203; Denominator: 5153; Percentage: 3.94%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1131.2; Denominator: 4940; Percentage: 22.9%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2828; Denominator: 4940; Percentage: 57.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1412; Denominator: 4940; Percentage: 28.58%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1696.8; Denominator: 4940; Percentage: 34.35%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 637; Denominator: 4940; Percentage: 12.89%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 635.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1575; Denominator: 4838; Percentage: 32.55%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3150; Denominator: 4838; Percentage: 65.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1243; Denominator: 3055; Percentage: 40.69%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1575; Denominator: 4838; Percentage: 32.55%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 670; Denominator: 3055; Percentage: 21.93%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 667.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1688; Denominator: 4810; Percentage: 35.09%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1688; Denominator: 4810; Percentage: 35.09%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women who know their HIV status</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women who know their HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 476365; Denominator: 655970; Percentage: 72.62%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 4858; Denominator: 629499; Percentage: 0.77%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 4858; Denominator: 629499; Percentage: 0.77%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 540106; Denominator: 675132; Percentage: 80%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 643512; Denominator: 675132; Percentage: 95.32%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 216042.4; Denominator: 675132; Percentage: 32%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 324063.6; Denominator: 675132; Percentage: 48%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 339932; Denominator: 675132; Percentage: 50.35%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 1173.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 299270; Denominator: 687976; Percentage: 43.5%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 598540; Denominator: 687976; Percentage: 87%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 607495; Denominator: 687976; Percentage: 88.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 299270; Denominator: 687976; Percentage: 43.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 283848; Denominator: 687976; Percentage: 41.26%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 607.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 332897; Denominator: 700835; Percentage: 47.5%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 332897; Denominator: 700835; Percentage: 47.5%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>KP-1a-Other: Percentage of men most exposed to HIV who had access to HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>KP-1a-Other: Percentage of men most exposed to HIV who had access to HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="120.97">
          <comment>
            <narrative>Numerator: 13996; Denominator: 11570.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="30.8">
            <comment>
              <narrative>Numerator: 6040.4; Denominator: 19612.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="77">
            <comment>
              <narrative>Numerator: 15101; Denominator: 19612.</narrative>
            </comment>
          </target>
          <actual value="78.37">
            <comment>
              <narrative>Numerator: 15369; Denominator: 19612.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="77">
            <comment>
              <narrative>Numerator: 15101; Denominator: 19612.</narrative>
            </comment>
          </target>
          <actual value="78.37">
            <comment>
              <narrative>Numerator: 15369; Denominator: 19612.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="79">
            <comment>
              <narrative>Numerator: 15865; Denominator: 20082.</narrative>
            </comment>
          </target>
          <actual value="126.66">
            <comment>
              <narrative>Numerator: 25436; Denominator: 20082.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="39.5">
            <comment>
              <narrative>Numerator: 7932.5; Denominator: 20082.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="79">
            <comment>
              <narrative>Numerator: 15865; Denominator: 20082.</narrative>
            </comment>
          </target>
          <actual value="126.66">
            <comment>
              <narrative>Numerator: 25436; Denominator: 20082.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="40.5">
            <comment>
              <narrative>Numerator: 3801; Denominator: 9385.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="55.5">
            <comment>
              <narrative>Numerator: 5209; Denominator: 9385.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for people who use drugs (PUD) and their sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 6022; Denominator: 928; Percentage: 648.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1096; Denominator: 928; Percentage: 118.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 4926; Denominator: 928; Percentage: 530.82%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6779; Denominator: 9824; Percentage: 69%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19392; Denominator: 9824; Percentage: 197.39%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2711.6; Denominator: 9824; Percentage: 27.6%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6779; Denominator: 9824; Percentage: 69%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19392; Denominator: 9824; Percentage: 197.39%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 21959.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3722; Denominator: 10060; Percentage: 37%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7444; Denominator: 10060; Percentage: 74%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9060; Denominator: 10060; Percentage: 90.06%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7444; Denominator: 10060; Percentage: 74%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9060; Denominator: 10060; Percentage: 90.06%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2481; Denominator: 6280; Percentage: 39.51%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3423; Denominator: 6280; Percentage: 54.51%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>KP-1c-Other Percentage of women most at risk of exposure to HIV who had access to HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>KP-1c-Other Percentage of women most at risk of exposure to HIV who had access to HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="91.64">
          <comment>
            <narrative>Numerator: 58402; Denominator: 63732.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="47">
            <comment>
              <narrative>Numerator: 28782.5; Denominator: 61239.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="94">
            <comment>
              <narrative>Numerator: 57565; Denominator: 61239.</narrative>
            </comment>
          </target>
          <actual value="91.85">
            <comment>
              <narrative>Numerator: 56247; Denominator: 61239.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="94">
            <comment>
              <narrative>Numerator: 57565; Denominator: 61239.</narrative>
            </comment>
          </target>
          <actual value="91.85">
            <comment>
              <narrative>Numerator: 56247; Denominator: 61239.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="47.5">
            <comment>
              <narrative>Numerator: 29786.5; Denominator: 62709.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 59573; Denominator: 62709.</narrative>
            </comment>
          </target>
          <actual value="146.56">
            <comment>
              <narrative>Numerator: 91906; Denominator: 62709.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 59573; Denominator: 62709.</narrative>
            </comment>
          </target>
          <actual value="146.56">
            <comment>
              <narrative>Numerator: 91906; Denominator: 62709.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="48">
            <comment>
              <narrative>Numerator: 31635; Denominator: 65906.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="63">
            <comment>
              <narrative>Numerator: 41521; Denominator: 65906.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of infants who received three doses of intermittent preventive treatment for malaria (IPTi)</narrative>
      </title>
      <description>
        <narrative>Module: Specific prevention interventions (SPI).</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Proportion of infants who received three doses of intermittent preventive treatment for malaria (IPTi)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 25195.5; Denominator: 100782; Percentage: 25%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 57; Denominator: 30222; Percentage: 0.19%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 25195.5; Denominator: 100782; Percentage: 25%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 57; Denominator: 30222; Percentage: 0.19%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 51341; Denominator: 102682; Percentage: 50%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria</narrative>
      </title>
      <description>
        <narrative>Module: Specific prevention interventions (SPI).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="58.74">
          <comment>
            <narrative>Numerator: 303901; Denominator: 517402.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="61.74">
            <comment>
              <narrative>Numerator: 164883; Denominator: 267061.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="61.7">
            <comment>
              <narrative>Numerator: 329766; Denominator: 534122.</narrative>
            </comment>
          </target>
          <actual value="51.63">
            <comment>
              <narrative>Numerator: 274594; Denominator: 531856.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="61.74">
            <comment>
              <narrative>Numerator: 164883; Denominator: 267061.</narrative>
            </comment>
          </target>
          <actual value="48.17">
            <comment>
              <narrative>Numerator: 134383; Denominator: 278980.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="65.74">
            <comment>
              <narrative>Numerator: 190056; Denominator: 289102.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="65.7">
            <comment>
              <narrative>Numerator: 380112; Denominator: 578204.</narrative>
            </comment>
          </target>
          <actual value="41.79">
            <comment>
              <narrative>Numerator: 227926; Denominator: 545459.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="65.74">
            <comment>
              <narrative>Numerator: 190056; Denominator: 289102.</narrative>
            </comment>
          </target>
          <actual value="36.71">
            <comment>
              <narrative>Numerator: 98946; Denominator: 269552.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="70.74">
            <comment>
              <narrative>Numerator: 232816; Denominator: 329115.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="70.74">
            <comment>
              <narrative>Numerator: 232816; Denominator: 329115.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="6788" />
        <baseline year="2022" iso-date="2022-12-31" value="6498">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="290">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="2195">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="4590">
          <dimension name="Gender" value="Male" />
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="7310" />
          <actual value="8001" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="3655" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="3655" />
          <actual value="4119" />
          <actual value="4013">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="147">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="1249">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="2911">
            <dimension name="Gender" value="Male" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <actual value="8615" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="3746" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="3840" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="3840" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="55">
          <comment>
            <narrative>Numerator: 1863; Denominator: 3387.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="57.02">
            <comment>
              <narrative>Numerator: 2084; Denominator: 3655.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="57">
            <comment>
              <narrative>Numerator: 4168; Denominator: 7310.</narrative>
            </comment>
          </target>
          <actual value="42.34">
            <comment>
              <narrative>Numerator: 3388; Denominator: 8001.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="57.02">
            <comment>
              <narrative>Numerator: 2084; Denominator: 3655.</narrative>
            </comment>
          </target>
          <actual value="42.27">
            <comment>
              <narrative>Numerator: 1741; Denominator: 4119.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="60.01">
            <comment>
              <narrative>Numerator: 2248; Denominator: 3746.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 4497; Denominator: 7493.</narrative>
            </comment>
          </target>
          <actual value="41.27">
            <comment>
              <narrative>Numerator: 3555; Denominator: 8615.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="60.02">
            <comment>
              <narrative>Numerator: 2249; Denominator: 3747.</narrative>
            </comment>
          </target>
          <actual value="47.36">
            <comment>
              <narrative>Numerator: 2015; Denominator: 4255.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="65">
            <comment>
              <narrative>Numerator: 2496; Denominator: 3840.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="65">
            <comment>
              <narrative>Numerator: 2496; Denominator: 3840.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31" value="3.8">
          <comment>
            <narrative>Numerator: 164; Denominator: 4320.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="5.01">
            <comment>
              <narrative>Numerator: 108; Denominator: 2156.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="5">
            <comment>
              <narrative>Numerator: 216; Denominator: 4313.</narrative>
            </comment>
          </target>
          <actual value="6.08">
            <comment>
              <narrative>Numerator: 303; Denominator: 4987.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="5.01">
            <comment>
              <narrative>Numerator: 108; Denominator: 2157.</narrative>
            </comment>
          </target>
          <actual value="13.57">
            <comment>
              <narrative>Numerator: 150; Denominator: 1105.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="7">
            <comment>
              <narrative>Numerator: 310; Denominator: 4421.</narrative>
            </comment>
          </target>
          <actual value="2.02">
            <comment>
              <narrative>Numerator: 174; Denominator: 8615.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="7.01">
            <comment>
              <narrative>Numerator: 155; Denominator: 2210.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="7.01">
            <comment>
              <narrative>Numerator: 155; Denominator: 2211.</narrative>
            </comment>
          </target>
          <actual value="1.9">
            <comment>
              <narrative>Numerator: 81; Denominator: 4255.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="7.99">
            <comment>
              <narrative>Numerator: 307; Denominator: 3840.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="8.02">
            <comment>
              <narrative>Numerator: 308; Denominator: 3840.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="94.88">
          <comment>
            <narrative>Numerator: 6741; Denominator: 7105.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="95.01">
            <comment>
              <narrative>Numerator: 3388; Denominator: 3566.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 6776; Denominator: 7132.</narrative>
            </comment>
          </target>
          <actual value="92.6">
            <comment>
              <narrative>Numerator: 6981; Denominator: 7539.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95.01">
            <comment>
              <narrative>Numerator: 3388; Denominator: 3566.</narrative>
            </comment>
          </target>
          <actual value="91.97">
            <comment>
              <narrative>Numerator: 3550; Denominator: 3860.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 6946; Denominator: 7310.</narrative>
            </comment>
          </target>
          <actual value="93.01">
            <comment>
              <narrative>Numerator: 7237; Denominator: 7781.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="95.02">
            <comment>
              <narrative>Numerator: 3473; Denominator: 3655.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95.02">
            <comment>
              <narrative>Numerator: 3473; Denominator: 3655.</narrative>
            </comment>
          </target>
          <actual value="92.51">
            <comment>
              <narrative>Numerator: 3581; Denominator: 3871.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="95.01">
            <comment>
              <narrative>Numerator: 3560; Denominator: 3747.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95.01">
            <comment>
              <narrative>Numerator: 3560; Denominator: 3747.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="1879" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="2257" />
          <actual value="3070" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="1128" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="1129" />
          <actual value="1891" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="2281" />
          <actual value="2739" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="1140" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="1141" />
          <actual value="1144" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="1157" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="1157" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <comment>
            <narrative>Numerator: 397; Denominator: 397.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 208; Denominator: 208.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 417; Denominator: 417.</narrative>
            </comment>
          </target>
          <actual value="98.94">
            <comment>
              <narrative>Numerator: 467; Denominator: 472.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 209; Denominator: 209.</narrative>
            </comment>
          </target>
          <actual value="99.19">
            <comment>
              <narrative>Numerator: 246; Denominator: 248.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 427; Denominator: 427.</narrative>
            </comment>
          </target>
          <actual value="92.02">
            <comment>
              <narrative>Numerator: 450; Denominator: 489.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 213; Denominator: 213.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 214; Denominator: 214.</narrative>
            </comment>
          </target>
          <actual value="92.34">
            <comment>
              <narrative>Numerator: 241; Denominator: 261.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 219; Denominator: 219.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 219; Denominator: 219.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2917; Denominator: 3286; Percentage: 88.77%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1616; Denominator: 3286; Percentage: 49.18%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1616; Denominator: 3286; Percentage: 49.18%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 779; Denominator: 3286; Percentage: 23.71%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 779; Denominator: 3286; Percentage: 23.71%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 522; Denominator: 3286; Percentage: 15.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 522; Denominator: 3286; Percentage: 15.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1424; Denominator: 3286; Percentage: 43.34%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1424; Denominator: 3286; Percentage: 43.34%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1493; Denominator: 3286; Percentage: 45.44%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1493; Denominator: 3286; Percentage: 45.44%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 458; Denominator: 498; Percentage: 91.97%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 916; Denominator: 996; Percentage: 92%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3622; Denominator: 5468; Percentage: 66.24%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 458; Denominator: 498; Percentage: 91.97%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1874; Denominator: 2658; Percentage: 70.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1808.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 34.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 32.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1211.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 663.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 946; Denominator: 996; Percentage: 95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4295; Denominator: 4527; Percentage: 94.88%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 473; Denominator: 498; Percentage: 94.98%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 473; Denominator: 498; Percentage: 94.98%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2306; Denominator: 2375; Percentage: 97.09%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2243.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 46.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 17.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1495.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 811.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 423; Denominator: 432; Percentage: 97.92%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 423; Denominator: 432; Percentage: 97.92%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 397; Denominator: 6788; Percentage: 5.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 397; Denominator: 6788; Percentage: 5.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 6761; Denominator: 6788; Percentage: 99.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 6366; Denominator: 6788; Percentage: 93.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 6366; Denominator: 6788; Percentage: 93.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 6736; Denominator: 6788; Percentage: 99.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 6736; Denominator: 6788; Percentage: 99.23%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7310; Denominator: 7310; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8001; Denominator: 8001; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3655; Denominator: 3655; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3655; Denominator: 3655; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4141; Denominator: 4119; Percentage: 100.53%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 3912.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 248.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7493; Denominator: 7493; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8498; Denominator: 8615; Percentage: 98.64%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3746; Denominator: 3746; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3747; Denominator: 3747; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4265; Denominator: 4255; Percentage: 100.24%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 4004.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 261.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3840; Denominator: 3840; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3840; Denominator: 3840; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="96.47">
          <comment>
            <narrative>Numerator: 72846; Denominator: 75508.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="63.74">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 48129; Denominator: 75508.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="63.74">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 48129; Denominator: 75508.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="32.73">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 24717; Denominator: 75508.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="32.73">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 24717; Denominator: 75508.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 72697; Denominator: 76523.</narrative>
            </comment>
          </target>
          <actual value="100.49">
            <comment>
              <narrative>Numerator: 76898; Denominator: 76523.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="94.54">
            <comment>
              <narrative>Numerator: 72345; Denominator: 76523.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 72697; Denominator: 76523.</narrative>
            </comment>
          </target>
          <actual value="100.49">
            <comment>
              <narrative>Numerator: 76898; Denominator: 76523.</narrative>
            </comment>
          </actual>
          <actual value="64.78">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 50269; Denominator: 77597.</narrative>
            </comment>
          </actual>
          <actual value="34.32">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 26629; Denominator: 77597.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="94.54">
            <comment>
              <narrative>Numerator: 73054; Denominator: 77275.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 73411; Denominator: 77275.</narrative>
            </comment>
          </target>
          <actual value="96.28">
            <comment>
              <narrative>Numerator: 75192; Denominator: 78100.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 73411; Denominator: 77275.</narrative>
            </comment>
          </target>
          <actual value="96.28">
            <comment>
              <narrative>Numerator: 75192; Denominator: 78100.</narrative>
            </comment>
          </actual>
          <actual value="63.06">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 49249; Denominator: 78100.</narrative>
            </comment>
          </actual>
          <actual value="33.22">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 25943; Denominator: 78100.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="94.6">
            <comment>
              <narrative>Numerator: 73727; Denominator: 77939.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 74042; Denominator: 77939.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="40.66">
          <comment>
            <narrative>Numerator: 2707; Denominator: 6658.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="20.25">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1348; Denominator: 6658.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="20.25">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1348; Denominator: 6658.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="20.41">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1359; Denominator: 6658.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="20.41">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1359; Denominator: 6658.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="47">
            <comment>
              <narrative>Numerator: 3068; Denominator: 6527.</narrative>
            </comment>
          </target>
          <actual value="33.72">
            <comment>
              <narrative>Numerator: 2201; Denominator: 6527.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="46.32">
            <comment>
              <narrative>Numerator: 3023; Denominator: 6527.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="47">
            <comment>
              <narrative>Numerator: 3068; Denominator: 6527.</narrative>
            </comment>
          </target>
          <actual value="33.72">
            <comment>
              <narrative>Numerator: 2201; Denominator: 6527.</narrative>
            </comment>
          </actual>
          <actual value="30.18">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1114; Denominator: 3691.</narrative>
            </comment>
          </actual>
          <actual value="29.45">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1087; Denominator: 3691.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="49.24">
            <comment>
              <narrative>Numerator: 3182; Denominator: 6462.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="51">
            <comment>
              <narrative>Numerator: 3296; Denominator: 6462.</narrative>
            </comment>
          </target>
          <actual value="47.51">
            <comment>
              <narrative>Numerator: 1948; Denominator: 4100.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="51.01">
            <comment>
              <narrative>Numerator: 3296; Denominator: 6462.</narrative>
            </comment>
          </target>
          <actual value="47.51">
            <comment>
              <narrative>Numerator: 1948; Denominator: 4100.</narrative>
            </comment>
          </actual>
          <actual value="23.46">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 962; Denominator: 4100.</narrative>
            </comment>
          </actual>
          <actual value="24.05">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 986; Denominator: 4100.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="53.77">
            <comment>
              <narrative>Numerator: 3440; Denominator: 6398.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="56">
            <comment>
              <narrative>Numerator: 3583; Denominator: 6398.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV and on ART with viral load test result</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="75.45">
          <comment>
            <narrative>Numerator: 57007; Denominator: 75553.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="74.73">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 54436; Denominator: 72846.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="74.73">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 54436; Denominator: 72846.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="94.98">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 2571; Denominator: 2707.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="94.98">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 2571; Denominator: 2707.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="76.11">
          <dimension name="Gender | Age" value="Female | 15+" />
          <comment>
            <narrative>Numerator: 36631; Denominator: 48129.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="76.11">
          <dimension name="Gender | Age" value="Female | 15+" />
          <comment>
            <narrative>Numerator: 36631; Denominator: 48129.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="72.04">
          <dimension name="Gender | Age" value="Male | 15+" />
          <comment>
            <narrative>Numerator: 17805; Denominator: 24717.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="72.04">
          <dimension name="Gender | Age" value="Male | 15+" />
          <comment>
            <narrative>Numerator: 17805; Denominator: 24717.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="85.7">
            <comment>
              <narrative>Numerator: 68221; Denominator: 79561.</narrative>
            </comment>
          </target>
          <actual value="80.1">
            <comment>
              <narrative>Numerator: 63358; Denominator: 79099.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="34.3">
            <comment>
              <narrative>Numerator: 27288.4; Denominator: 79561.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="85.75">
            <comment>
              <narrative>Numerator: 68221; Denominator: 79561.</narrative>
            </comment>
          </target>
          <actual value="80.1">
            <comment>
              <narrative>Numerator: 63358; Denominator: 79099.</narrative>
            </comment>
          </actual>
          <actual value="79.26">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 60947; Denominator: 76898.</narrative>
            </comment>
          </actual>
          <actual value="109.54">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2411; Denominator: 2201.</narrative>
            </comment>
          </actual>
          <actual value="80.78">
            <dimension name="Gender | Age" value="Female | 15+" />
            <comment>
              <narrative>Numerator: 40606; Denominator: 50269.</narrative>
            </comment>
          </actual>
          <actual value="76.39">
            <dimension name="Gender | Age" value="Male | 15+" />
            <comment>
              <narrative>Numerator: 20341; Denominator: 26629.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90.5">
            <comment>
              <narrative>Numerator: 73540; Denominator: 81223.</narrative>
            </comment>
          </target>
          <actual value="76.03">
            <comment>
              <narrative>Numerator: 58647; Denominator: 77140.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="45.27">
            <comment>
              <narrative>Numerator: 36770; Denominator: 81223.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90.54">
            <comment>
              <narrative>Numerator: 73540; Denominator: 81223.</narrative>
            </comment>
          </target>
          <actual value="76.03">
            <comment>
              <narrative>Numerator: 58647; Denominator: 77140.</narrative>
            </comment>
          </actual>
          <actual value="75.44">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 56725; Denominator: 75192.</narrative>
            </comment>
          </actual>
          <actual value="98.67">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1922; Denominator: 1948.</narrative>
            </comment>
          </actual>
          <actual value="78.33">
            <dimension name="Gender | Age" value="Female | 15+" />
            <comment>
              <narrative>Numerator: 38578; Denominator: 49249.</narrative>
            </comment>
          </actual>
          <actual value="69.95">
            <dimension name="Gender | Age" value="Male | 15+" />
            <comment>
              <narrative>Numerator: 18147; Denominator: 25943.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="47.61">
            <comment>
              <narrative>Numerator: 39259; Denominator: 82458.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95.22">
            <comment>
              <narrative>Numerator: 78518; Denominator: 82458.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="80.69">
          <comment>
            <narrative>Numerator: 4158; Denominator: 5153.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="88.1">
            <comment>
              <narrative>Numerator: 4350; Denominator: 4940.</narrative>
            </comment>
          </target>
          <actual value="53.04">
            <comment>
              <narrative>Numerator: 2620; Denominator: 4940.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="35.22">
            <comment>
              <narrative>Numerator: 1740; Denominator: 4940.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="52.83">
            <comment>
              <narrative>Numerator: 2610; Denominator: 4940.</narrative>
            </comment>
          </target>
          <actual value="28.52">
            <comment>
              <narrative>Numerator: 1409; Denominator: 4940.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 4500; Denominator: 4838.</narrative>
            </comment>
          </target>
          <actual value="65.01">
            <comment>
              <narrative>Numerator: 1986; Denominator: 3055.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="46.51">
            <comment>
              <narrative>Numerator: 2250; Denominator: 4838.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="46.51">
            <comment>
              <narrative>Numerator: 2250; Denominator: 4838.</narrative>
            </comment>
          </target>
          <actual value="29.56">
            <comment>
              <narrative>Numerator: 903; Denominator: 3055.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="46.78">
            <comment>
              <narrative>Numerator: 2250; Denominator: 4810.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="46.78">
            <comment>
              <narrative>Numerator: 2250; Denominator: 4810.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of insecticide-treated nets distributed to populations at risk of malaria transmission through mass campaigns</narrative>
      </title>
      <description>
        <narrative>Module: Vector control.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of insecticide-treated nets distributed to populations at risk of malaria transmission through mass campaigns</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="6548442" />
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="7843669.8" />
          <actual value="7340025" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="7843669.78" />
          <actual value="7340025" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of insecticide-treated nets distributed to targeted risk groups through continuous distribution</narrative>
      </title>
      <description>
        <narrative>Module: Vector control.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of insecticide-treated nets distributed to targeted risk groups through continuous distribution</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="982151" />
        <baseline year="2022" iso-date="2022-12-31" value="367371">
          <dimension name="Target / Risk population group" value="Children 0-5" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="367371">
          <dimension name="Target / Risk population group" value="Children 0-5" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="500572">
          <dimension name="Target / Risk population group" value="Pregnant women" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="500572">
          <dimension name="Target / Risk population group" value="Pregnant women" />
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="609162.5" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="1218325" />
          <actual value="978167" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="609162.5" />
          <actual value="506548" />
          <actual value="190905">
            <dimension name="Target / Risk population group" value="Children 0-5" />
          </actual>
          <actual value="256241">
            <dimension name="Target / Risk population group" value="Pregnant women" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="706091" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="1412182" />
          <actual value="899352" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="706091" />
          <actual value="448797" />
          <actual value="352630">
            <dimension name="Target / Risk population group" value="Children 0-5" />
          </actual>
          <actual value="465396">
            <dimension name="Target / Risk population group" value="Pregnant women" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="650148" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="650148" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of population at risk receiving at least one round of IRS within the last 12 months in areas targeted for IRS</narrative>
      </title>
      <description>
        <narrative>Module: Vector control.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of population at risk receiving at least one round of IRS within the last 12 months in areas targeted for IRS</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="91.05">
          <comment>
            <narrative>Numerator: 1083933; Denominator: 1190484.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1118896; Denominator: 1177785.</narrative>
            </comment>
          </target>
          <actual value="93.93">
            <comment>
              <narrative>Numerator: 1177190; Denominator: 1253245.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1118896; Denominator: 1177785.</narrative>
            </comment>
          </target>
          <actual value="93.93">
            <comment>
              <narrative>Numerator: 1177190; Denominator: 1253245.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>